Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Proteome Sciences Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 0/6
Proteome Sciences has a total shareholder equity of £-5.3M and total debt of £11.7M, which brings its debt-to-equity ratio to -221.8%. Its total assets and total liabilities are £9.5M and £14.7M respectively.
Anahtar bilgiler
-221.8%
Borç/özkaynak oranı
UK£11.68m
Borç
Faiz karşılama oranı | n/a |
Nakit | UK£1.21m |
Eşitlik | -UK£5.27m |
Toplam yükümlülükler | UK£14.72m |
Toplam varlıklar | UK£9.45m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely
May 10Here's Why We Think Proteome Sciences (LON:PRM) Is Well Worth Watching
Dec 02Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors
Aug 25Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors
Dec 22Do Proteome Sciences' (LON:PRM) Earnings Warrant Your Attention?
Sep 03Calculating The Fair Value Of Proteome Sciences plc (LON:PRM)
Jan 27Does Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?
May 31Some Confidence Is Lacking In Proteome Sciences plc's (LON:PRM) P/E
Apr 04Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: PRM has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Uzun Vadeli Yükümlülükler: PRM has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: PRM has negative shareholder equity, which is a more serious situation than a high debt level.
Borcun Azaltılması: PRM's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: Insufficient data to determine if PRM has enough cash runway based on its current free cash flow.
Tahmini Nakit Akışı: Insufficient data to determine if PRM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.